Gastroenterology Calculators

All Gastroenterology calculators

Inflammatory bowel disease is managed by numbers as much as by symptoms, and acute pancreatitis is triaged by them. These three tools cover both ends of gastroenterology: two activity indices that decide whether Crohn's disease and ulcerative colitis are in remission or flaring, and the classic prognostic criteria that sort pancreatitis into mild and severe. Small library, but every item earns its place on the ward round.

Medically reviewed by Dr. Taimoor Asghar, physician.

In short: Free gastroenterology calculators: CDAI for Crohn's disease, the Mayo score for ulcerative colitis and Ranson's criteria for pancreatitis prognosis. Browse the calculators below, each with an interpretation guide.

What gastroenterology covers, and the clinical questions these tools answer

Gastroenterology covers the luminal gut from oesophagus to rectum, and two of its most consequential jobs are quantifying inflammatory bowel disease and predicting the course of acute pancreatitis. In Crohn's disease the question is whether the patient is in remission, responding to treatment, or flaring despite it; the Crohn's Disease Activity Index, the CDAI, answers with a score from 0 to 600 built from stool frequency, pain, wellbeing, complications, medications, physical findings and laboratory markers. In ulcerative colitis the equivalent question is answered by the Mayo score, which combines stool frequency, rectal bleeding, endoscopic findings and the physician's global assessment into a score from 0 to 12.

Acute pancreatitis asks a different question: this patient is in pain with raised amylase, but will they recover with fluids and time or deteriorate into necrosis, organ failure and the intensive care unit? Ranson's criteria answer with eleven clinical and laboratory parameters, five scored at admission and six at forty-eight hours, producing a total from 0 to 11 that tracks closely with mortality. Together the three tools turn subjective impressions into scores that can be compared across visits, across clinicians and across trials.

When clinicians and students use these calculators

The CDAI is scored in the inflammatory bowel disease clinic, where treatment decisions hinge on it: starting or escalating therapy, judging response at follow-up, and defining remission in a way that both clinician and patient can agree on. It also underpins clinical trials, where a defined fall in the score is the standard measure of response. The Mayo score is used in the same setting for ulcerative colitis, and its endoscopic component means it is usually completed around the time of flexible sigmoidoscopy or colonoscopy, tying the visual findings to the symptoms in one number.

Ranson's criteria are scored in the emergency department and on the acute medical ward, where the admission parameters sort patients into risk groups from the first blood tests and the forty-eight-hour parameters refine the picture. A rising score prompts escalation: aggressive fluid resuscitation, nutritional support planning, imaging for necrosis, and early critical care involvement. For students, these three scores are high-yield because they are compact, memorable and constantly examined: know the components, know the cutoffs, and know what each score changes.

How to interpret results, and what they change in practice

A CDAI below 150 defines remission, 150 to 220 is mildly active disease, 220 to 450 is moderately to severely active, and above 450 is severe. A fall of 70 to 100 points is the conventional marker of clinical response, and these thresholds directly drive therapy: remission means maintain, active disease means escalate, and severe disease despite treatment means rethink the strategy entirely. The Mayo score reads similarly: 0 to 1 is remission, 2 to 4 is mild, 5 to 6 is moderate when the endoscopy is included as the full score runs to 12, and higher scores mean more severe disease requiring more intensive therapy.

Ranson's criteria are interpreted by count: 0 to 2 criteria at admission suggest mild pancreatitis with very low mortality, 3 to 4 indicate increasingly severe disease, 5 to 6 mark severe pancreatitis with substantial mortality, and above 6 carries a very high risk. In practice the score does not make the diagnosis, imaging and the clinical picture do that, but it quantifies the prognosis early enough to change the level of care, the urgency of imaging, and the threshold for critical care referral. Documenting the score also protects the team: the reasoning behind escalation is visible in the notes.

Limitations and pitfalls

The CDAI is cumbersome: it needs a seven-day diary of stool frequency, pain and wellbeing, and two of its most heavily weighted items, general wellbeing and abdominal pain, are entirely subjective. Two patients with the same bowel inflammation can score very differently, and the score correlates imperfectly with endoscopic healing, which is why modern practice increasingly pairs it with faecal calprotectin and imaging. The Mayo score's endoscopic subscore requires an endoscopy, so it cannot be completed at every visit, and the physician's global assessment introduces the very subjectivity the score is trying to escape.

Ranson's criteria take forty-eight hours to complete, which is an eternity in a deteriorating patient; they are a prognostic instrument, not a real-time monitor, and they should never delay escalation that the clinical picture already demands. The criteria were derived decades ago and do not incorporate modern imaging or scoring systems, so many units now use them alongside alternatives. None of the three scores diagnoses anything: they quantify activity and prognosis once the diagnosis is established.

How to use this library

Score the CDAI at every inflammatory bowel disease review where treatment might change, and pair it with an objective marker such as faecal calprotectin so subjective symptoms and mucosal healing are both visible. Complete the Mayo score around endoscopy so symptoms and mucosal findings are captured together. Calculate Ranson's criteria at admission for every acute pancreatitis, repeat at forty-eight hours, and act on the trajectory: a rising score is the signal to escalate before the patient forces your hand.

Related specialities

Frequently asked questions

What is the CDAI?

The Crohn's Disease Activity Index is a score from 0 to 600 that quantifies Crohn's disease activity from stool frequency, abdominal pain, general wellbeing, complications, antidiarrhoeal use, abdominal mass, haematocrit and weight. A score below 150 defines remission, and it is the standard measure of disease activity in clinics and clinical trials.

What is the Mayo score for ulcerative colitis?

The Mayo score grades ulcerative colitis activity from 0 to 12 using stool frequency, rectal bleeding, endoscopic findings and the physician's global assessment. A score of 0 to 1 indicates remission. Because it includes an endoscopic component, it is usually completed around the time of endoscopy.

What does Ranson's criteria predict?

Ranson's criteria predict the severity and mortality of acute pancreatitis from eleven clinical and laboratory parameters, five at admission and six at forty-eight hours. Scores of 0 to 2 suggest mild disease with very low mortality, while scores of 5 or more indicate severe pancreatitis with substantial risk, guiding the level of care and urgency of imaging.

How often should IBD activity scores be repeated?

Repeat them whenever the result could change management: at diagnosis, when starting or changing therapy, at scheduled follow-up to judge response, and during a suspected flare. In stable remission, scoring at routine clinic visits is enough, paired with objective markers such as faecal calprotectin.

Can these scores replace endoscopy?

No. Activity scores measure symptoms, examination findings and basic laboratories, while endoscopy shows the mucosa itself. Treatment targets increasingly aim for mucosal healing as well as symptom control, so the scores and the scope are complementary, not interchangeable.

Medical disclaimer

These calculators are educational tools for clinicians, students and informed readers. They do not provide medical advice, and no score or result should replace the judgement of a qualified health professional who has seen the patient. If you are unwell or worried about a result, seek professional care promptly.